Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

The isopeptidase USP2a protects human prostate cancer from apoptosis.

Priolo C, Tang D, Brahamandan M, Benassi B, Sicinska E, Ogino S, Farsetti A, Porrello A, Finn S, Zimmermann J, Febbo P, Loda M.

Cancer Res. 2006 Sep 1;66(17):8625-32.

2.

The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.

Graner E, Tang D, Rossi S, Baron A, Migita T, Weinstein LJ, Lechpammer M, Huesken D, Zimmermann J, Signoretti S, Loda M.

Cancer Cell. 2004 Mar;5(3):253-61.

3.

MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer.

Benassi B, Flavin R, Marchionni L, Zanata S, Pan Y, Chowdhury D, Marani M, Strano S, Muti P, Blandino G, Loda M.

Cancer Discov. 2012 Mar;2(3):236-47. doi: 10.1158/2159-8290.CD-11-0219. Epub 2012 Jan 5.

4.

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.

Berezovska OP, Glinskii AB, Yang Z, Li XM, Hoffman RM, Glinsky GV.

Cell Cycle. 2006 Aug;5(16):1886-901. Epub 2006 Aug 15.

PMID:
16963837
5.

The ubiquitin-specific protease USP2a enhances tumor progression by targeting cyclin A1 in bladder cancer.

Kim J, Kim WJ, Liu Z, Loda M, Freeman MR.

Cell Cycle. 2012 Mar 15;11(6):1123-30. doi: 10.4161/cc.11.6.19550. Epub 2012 Mar 15.

6.
7.

Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo.

Du YF, Shi Y, Xing YF, Zeng FQ.

J Cancer Res Clin Oncol. 2008 Nov;134(11):1255-64. doi: 10.1007/s00432-008-0394-2. Epub 2008 Apr 23. Erratum in: J Cancer Res Clin Oncol. 2008 Nov;134(11):1265. Xing, Yi-fei [corrected to Xing, Yi-Fei]; Zeng, Fu-qing [corrected to Zeng, Fu-Qing].

PMID:
18431597
8.

ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.

Asirvatham AJ, Carey JP, Chaudhary J.

Prostate. 2007 Sep 15;67(13):1411-20.

PMID:
17639499
9.

Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.

Hua D, Liu MY, Cheng ZD, Qin XJ, Zhang HM, Chen Y, Qin GJ, Liang G, Li JN, Han XF, Liu DX.

Mol Immunol. 2009 Sep;46(15):2876-84. doi: 10.1016/j.molimm.2009.06.016. Epub 2009 Jul 29.

PMID:
19643479
10.
11.

Metallothionein is up-regulated under hypoxia and promotes the survival of human prostate cancer cells.

Yamasaki M, Nomura T, Sato F, Mimata H.

Oncol Rep. 2007 Nov;18(5):1145-53.

PMID:
17914565
12.

Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.

Aloy MT, Hadchity E, Bionda C, Diaz-Latoud C, Claude L, Rousson R, Arrigo AP, Rodriguez-Lafrasse C.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):543-53. Epub 2007 Nov 5.

PMID:
17980509
13.

Microarray analysis identifies differentially expressed genes induced by human papillomavirus type 18 E6 silencing RNA.

Min W, Wen-li M, Zhao-hui S, Ling L, Bao Z, Wen-ling Z.

Int J Gynecol Cancer. 2009 May;19(4):547-63. doi: 10.1111/IGC.0b013e3181a44c68.

PMID:
19509549
15.

Increased expression of apoptosis inhibitor protein XIAP contributes to anoikis resistance of circulating human prostate cancer metastasis precursor cells.

Berezovskaya O, Schimmer AD, Glinskii AB, Pinilla C, Hoffman RM, Reed JC, Glinsky GV.

Cancer Res. 2005 Mar 15;65(6):2378-86.

16.

Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells.

Li X, Chen D, Yin S, Meng Y, Yang H, Landis-Piwowar KR, Li Y, Sarkar FH, Reddy GP, Dou QP, Sheng S.

J Cell Physiol. 2007 Aug;212(2):298-306.

PMID:
17458898
17.

Annexin-A7 protects normal prostate cells and induces distinct patterns of RB-associated cytotoxicity in androgen-sensitive and -resistant prostate cancer cells.

Torosyan Y, Simakova O, Naga S, Mezhevaya K, Leighton X, Diaz J, Huang W, Pollard H, Srivastava M.

Int J Cancer. 2009 Dec 1;125(11):2528-39. doi: 10.1002/ijc.24592.

18.

Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.

Shen J, Liu J, Long Y, Miao Y, Su M, Zhang Q, Han H, Hao X.

Acta Biochim Biophys Sin (Shanghai). 2009 Mar;41(3):223-30.

20.

Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.

Haram KM, Peltier HJ, Lu B, Bhasin M, Otu HH, Choy B, Regan M, Libermann TA, Latham GJ, Sanda MG, Arredouani MS.

Prostate. 2008 Oct 1;68(14):1517-30. doi: 10.1002/pros.20803.

PMID:
18668517
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk